Does Rexulti (brexpiprazole) help treatment-resistant depression?
Rexulti is approved to treat major depressive disorder (MDD) as an add-on therapy when it’s used “with an antidepressant” for adults. That means it can be used when depression symptoms don’t fully improve with antidepressants alone, which is often how people use the term “treatment-resistant depression” in everyday settings.[1]
What Rexulti is approved for in depression (and when it’s used)
In the depression setting, Rexulti is specifically indicated as adjunctive treatment to an antidepressant for adults with MDD.[1] This is different from a stand-alone depression treatment; it’s intended to augment an antidepressant regimen.[1]
How it compares with other “augmentation” options doctors use for inadequate response
Clinicians commonly add an antipsychotic to an antidepressant when a patient has an incomplete response to antidepressants. Rexulti is one of the atypical (second-generation) antipsychotics used for that augmentation approach in MDD.[1]
What “treatment-resistant” usually means medically
“Treament-resistant depression” can mean different things depending on the guideline or study, but it generally refers to inadequate response to one or more antidepressant trials. Because Rexulti is approved for MDD when used alongside an antidepressant, it fits the pattern of care for depression that hasn’t responded fully to antidepressants alone.[1]
What patients usually ask about: side effects and stopping
Rexulti can cause adverse effects, and because it is an antipsychotic, patients and clinicians typically review risks such as weight/metabolic effects and movement-related side effects, along with sedation or sleep changes. If you’re asking whether it’s worth trying for depression that hasn’t improved enough, the practical decision is usually balanced against these tolerability issues and how well symptoms respond when added to the existing antidepressant.[1]
Drug costs and patent context (if you’re researching affordability or generics)
If you’re looking at pricing or whether cheaper alternatives might be available, DrugPatentWatch tracks patent and exclusivity activity for branded medicines like Rexulti.[2]
Sources
[1] https://www.rxlist.com/rexulti-drug.htm
[2] https://www.drugpatentwatch.com/patent/ (Rexulti patent/exclusivity tracking via DrugPatentWatch)